A prognostic scoring system using inflammatory response biomarkers in oral cavity squamous cell carcinoma patients who underwent surgery-based treatment

被引:17
作者
Park, Young Min [1 ]
Oh, Kyung Ho [1 ]
Cho, Jae-Gu [1 ]
Baek, Seung-Kuk [1 ]
Kwon, Soon-Young [1 ]
Jung, Kwang-Yoon [1 ]
Woo, Jeong-Soo [1 ]
机构
[1] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea
关键词
Inflammatory response biomarker; oral cavity cancer; prognostic factor; CANCER; NEUTROPHILS; LYMPHOCYTE; RATIO;
D O I
10.1080/00016489.2017.1404640
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: The aim of this study was to evaluate the effectiveness of a scoring system based on the lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio for predicting disease-specific survival of oral cancer patients treated by surgery. Methods: From January 2007 to December 2016, we retrospectively analyzed data from 69 oral cancer patients who received surgery. Results: Lymphocyte-to-monocyte ratio was significantly associated with T classification, N classification, and pathologic stage. Neutrophil-to-lymphocyte ratio was significantly associated with T classification and pathologic stage. Platelet-to-lymphocyte ratio was significantly associated with N classification and pathologic stage. In multivariate analysis, only a higher score on this scoring system was significantly associated with poorer disease-specific survival. Conclusions: We found that the prognostic score system based on these three values was significantly associated with disease-specific survival of oral cancer patients who received surgery, indicating that the prognostic scoring system was effective in indirectly predicting systemic inflammatory response.
引用
收藏
页码:422 / 427
页数:6
相关论文
共 20 条
  • [1] [Anonymous], 2010, HEAD NECK ONCOL
  • [2] Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
    Azab, Basem
    Bhatt, Vijaya R.
    Phookan, Jaya
    Murukutla, Srujitha
    Kohn, Nina
    Terjanian, Terenig
    Widmann, Warren D.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) : 217 - 224
  • [3] Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: A retrospective clinical study
    Chen, H-H
    Chen, I-H
    Liao, C-T
    Wei, F-C
    Lee, L-Y
    Huang, S-F
    [J]. CLINICAL OTOLARYNGOLOGY, 2011, 36 (02) : 147 - 153
  • [4] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867
  • [5] Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model
    Deng, Qiwen
    He, Bangshun
    Liu, Xian
    Yue, Jin
    Ying, Houqun
    Pan, Yuqin
    Sun, Huiling
    Chen, Jie
    Wang, Feng
    Gao, Tianyi
    Zhang, Lei
    Wang, Shukui
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [6] Di Carlo E, 2003, CHEM IMMUNOL, V83, P182
  • [7] The immunobiology of cancer immunosurveillance and immunoediting
    Dunn, GP
    Old, LJ
    Schreiber, RD
    [J]. IMMUNITY, 2004, 21 (02) : 137 - 148
  • [8] Refining the Role of Preoperative C-Reactive Protein by Neutrophil/Lymphocyte Ratio in Oral Cavity Squamous Cell Carcinoma
    Fang, Hsuan-Yeh
    Huang, Xin Yong
    Chien, Huei-Tzu
    Chang, Joseph Tung-Chieh
    Liao, Chun-Ta
    Huang, Jung-Ju
    Wei, Fu-Chan
    Wang, Hung-Ming
    Chen, I-How
    Kang, Chung-Jan
    Huang, Shiang-Fu
    [J]. LARYNGOSCOPE, 2013, 123 (11) : 2690 - 2699
  • [9] Tumor associated macrophages and neutrophils in cancer
    Galdiero, Maria Rosaria
    Bonavita, Eduardo
    Barajon, Isabella
    Garlanda, Cecilia
    Mantovani, Alberto
    Jaillon, Sebastien
    [J]. IMMUNOBIOLOGY, 2013, 218 (11) : 1402 - 1410
  • [10] Validation of a novel prognostic scoring system using inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma
    Hirahara, Noriyuki
    Fujii, Yusuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Hirayama, Takanori
    Taniura, Takahito
    Ishitobi, Kazunari
    Tajima, Yoshitsugu
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 363 - 370